Treats generalized tonic-clonic status epilepticus, and prevention and treatment of…. ANDA 84307, held by Hikma. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 84307 (Phenytoin Sodium), held by Hikma, was first approved by FDA on Jul 16, 1975, with 30 approved supplements and 0 published complete response letters.
Parenteral Phenytoin Sodium Injection is indicated for the treatment of generalized tonic-clonic status epilepticus, and prevention and treatment of seizures occurring during neurosurgery. Intravenous phenytoin can also be substituted, as short-term use, for oral phenytoin. Parenteral phenytoin should be used only when oral phenytoin administration is not possible. Parenteral Phenytoin Sodium Injection is indicated for the treatment of generalized tonic clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery. Intravenous phenytoin can also be substituted, as short-term use, for oral phenytoin.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 16, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenytoin Sodium50MG/ML · injectable;injection | Phenytoin Sodium | RxReference drug |
| Feb 16, 2021 | Supplement 62Labeling · Standard review | Approved | None posted |
| Sep 28, 2020 | Supplement 60Labeling · Standard review | Approved | None posted |
| Sep 28, 2020 | Supplement 57Labeling · Standard review | Approved | None posted |
| Sep 28, 2020 | Supplement 56Labeling · Standard review | Approved | None posted |
| Sep 28, 2020 | Supplement 54Labeling · Standard review | Approved | None posted |
| Sep 28, 2020 | Supplement 51Labeling · Standard review | Approved | None posted |
| Sep 28, 2020 | Supplement 49Labeling · Standard review | Approved | None posted |
| Sep 28, 2020 | Supplement 48Labeling · Standard review | Approved | None posted |
| Jan 27, 2014 | Supplement 47Labeling · Standard review | Approved | None posted |
| Jan 27, 2014 | Supplement 46Labeling | Approved | None posted |
| Dec 11, 1998 | Supplement 38Labeling | Approved | None posted |
| Aug 19, 1998 | Supplement 37Labeling | Approved | None posted |
| Feb 9, 1998 | Supplement 36Manufacturing | Approved | None posted |
| Jun 10, 1997 | Supplement 33Manufacturing | Approved | None posted |
| May 27, 1997 | Supplement 35Manufacturing | Approved | None posted |
| May 27, 1997 | Supplement 34Manufacturing | Approved | None posted |
| Nov 27, 1995 | Supplement 32Labeling | Approved | None posted |
| Nov 18, 1993 | Supplement 31Manufacturing | Approved | None posted |
| Jul 31, 1991 | Supplement 29Manufacturing | Approved | None posted |
| Dec 28, 1990 | Supplement 28Labeling | Approved | None posted |
| May 18, 1990 | Supplement 27Manufacturing | Approved | None posted |
| Jul 24, 1989 | Supplement 26Manufacturing | Approved | None posted |
| Aug 10, 1988 | Supplement 24Labeling | Approved | None posted |
| Oct 2, 1987 | Supplement 20Manufacturing | Approved | None posted |
| Oct 2, 1987 | Supplement 19Manufacturing | Approved | None posted |
| Oct 2, 1987 | Supplement 18Manufacturing | Approved | None posted |
| Nov 18, 1985 | Supplement 22Manufacturing | Approved | None posted |
| Apr 18, 1985 | Supplement 17Manufacturing | Approved | None posted |
| May 1, 1984 | Supplement 15Manufacturing | Approved | None posted |
| Feb 14, 1983 | Supplement 13Manufacturing | Approved | None posted |
| Jul 16, 1975 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters